Genotype III-Based Japanese Encephalitis Vaccines Exhibit Diminished Neutralizing Response to Reemerging Genotype V
Our study underscores that current GIII-based vaccines do not provide comparable protection against GV JEVs, impacting individuals in both current and potential endemic regions, as well as travelers to these regions.
Authors
- Sang‐Uk Seo (ORCID: https://orcid.org/0000-0002-6633-1932)
- Ji‐Man Kang (ORCID: https://orcid.org/0000-0002-0678-4964)
- Hee Il Lee
- Haeyoun Choi (ORCID: https://orcid.org/0000-0002-3406-4438)
- Hyeon‐Seok Eom (ORCID: https://orcid.org/0000-0002-0484-2067)
- Seong‐Jun Kim (ORCID: https://orcid.org/0000-0001-8504-2872)
- Ahra Lee
- Sang‐Hyun Kim (ORCID: https://orcid.org/0000-0001-8026-1582)
- Woo Jin Kim (ORCID: https://orcid.org/0000-0003-2927-370X)
- Tomohiro Ishikawa
- Jae Min Song
- Su-Yeon Hong (ORCID: https://orcid.org/0009-0002-5667-7910)
- Sang‐Mu Shim
Institutions
- Sungshin Women's University (KR)
- Yonsei University (KR)
- Severance Hospital (KR)
- National Cancer Center (US)
- Korea National Institute of Health (KR)
- National Cancer Center (KR)
- Korea Disease Control and Prevention Agency (KR)
- Korea Research Institute of Chemical Technology (KR)
- Dokkyo Medical University (JP)
- Catholic University of Korea (KR)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1093/infdis/jiae589
- Citations
- 10
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 5.43